Is digital rectal examination still necessary in the early detection of prostate cancer?

被引:6
作者
Quinlan, M. R. [1 ,2 ]
Teahan, S. [2 ]
Mulvin, D. [2 ]
Quinlan, D. M. [2 ]
机构
[1] Blackrock Co, Dublin, Ireland
[2] St Vincent Univ Hosp, Dept Urol, Dublin, Ireland
关键词
prostate cancer; PSA; DRE; TRUS biopsy;
D O I
10.1007/s11845-007-0018-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background PSA measurement is important in prostate cancer detection. However, applying cut- off values of > 4 ng/ ml as indication for biopsy misses 20-30% of tumours. Aims To determine the number of patients with prostate cancer and normal age-related PSA, referred for TRUS biopsy due to abnormal DRE alone. Methods We reviewed patients referred for biopsy over 12 months. Indication for biopsy included abnormal PSA, abnormal DRE, or both. Results Four-hundred and sixty-five (465) TRUS biopsies were performed, 209 were positive. Of the 183 (183/209) positive on whom complete data were available, 4 (2.2%) had a normal age-related PSA but an abnormal DRE. Conclusions Metastatic prostate cancer remains incurable. Therefore detection of organ-confined and potentially curable disease, is crucial. Though PSA has led to earlier detection, this study emphasises the importance of clinical examination, illustrating a normal PSA cannot eliminate the possibility of cancer. DRE and PSA should be interpreted as being collaborative, not competitive.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 11 条
[1]  
AGRYOPOULOS A, 2005, SCAND J UROL NEPHROL, V39, P289
[2]  
Brawer MK, 1999, UROLOGY, V54, P2
[3]  
Candas B, 2000, PROSTATE, V45, P19
[4]   PREVALENCE AND PATHOLOGICAL EXTENT OF PROSTATE-CANCER IN MEN WITH PROSTATE SPECIFIC ANTIGEN LEVELS OF 2.9 TO 4.0 NG/ML [J].
COLBERG, JW ;
SMITH, DS ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1993, 149 (03) :507-509
[5]   Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.:: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests [J].
Mäkinen, T ;
Tammela, TLJ ;
Hakama, M ;
Stenman, UH ;
Rannikko, S ;
Aro, J ;
Juusela, H ;
Määttänen, L ;
Auvinen, A .
JOURNAL OF UROLOGY, 2001, 166 (04) :1339-1342
[6]   Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice [J].
Ng, TK ;
Vasilareas, D ;
Mitterdorfer, AJ ;
Maher, PO ;
Lalak, A .
BJU INTERNATIONAL, 2005, 95 (04) :545-548
[7]   Metastatic prostate cancer with normal level of serum prostate-specific antigen [J].
R. Nishio ;
Y. Furuya ;
O. Nagakawa ;
H. Fuse .
International Urology and Nephrology, 2003, 35 (2) :189-192
[8]  
Oesterling J E, 1994, Can J Oncol, V4 Suppl 1, P52
[9]   Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? [J].
Philip, J ;
Roy, SD ;
Ballal, M ;
Foster, CS ;
Javlé, P .
BJU INTERNATIONAL, 2005, 95 (07) :969-971
[10]   Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997 [J].
Roberts, RO ;
Bergstralh, EJ ;
Lieber, MM ;
Jacobsen, SJ .
UROLOGY, 2000, 56 (05) :817-822